State Street
RNTX

State Street’s Rein Therapeutics RNTX Stock Holding History

State Street’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.7K Hold
75,904
– – ﹤0.01% 4029
2025
Q4 		$88K Buy
75,904
+59,900
+374% +$82.5K ﹤0.01% 4065
2025
Q3 		$18.3K Hold
16,004
– – ﹤0.01% 4254
2025
Q2 		$22.4K Hold
16,004
– – ﹤0.01% 4190
2025
Q1 		$28.3K Hold
16,004
– – ﹤0.01% 4166
2024
Q4 		$36.8K Buy
16,004
+5,600
+54% +$17K ﹤0.01% 4155
2024
Q3 		$36.8K Hold
10,404
– – ﹤0.01% 4144
2024
Q2 		$28.8K Buy
+10,404
New +$42.8K ﹤0.01% 4235
2022
Q4 		– Sell
-5,104
Closed -$21K – 4904
2022
Q3 		$21K Hold
5,104
– – ﹤0.01% 4827
2022
Q2 		$27K Buy
5,104
+1,544
+43% +$14.2K ﹤0.01% 4835
2022
Q1 		$36K Hold
3,560
– – ﹤0.01% 4845
2021
Q4 		$40K Hold
3,560
– – ﹤0.01% 4732
2021
Q3 		$73K Hold
3,560
– – ﹤0.01% 4606
2021
Q2 		$89K Buy
+3,560
New +$88.8K ﹤0.01% 4384
2018
Q2 		– Sell
-1,893
Closed -$309K – 3807
2018
Q1 		$309K Buy
1,893
+270
+17% +$48.1K ﹤0.01% 3499
2017
Q4 		$342K Buy
1,623
+764
+89% +$183K ﹤0.01% 3504
2017
Q3 		$229K Buy
+859
New +$215K ﹤0.01% 3586

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

State Street's RNTX Position: Q1 2026 in Review

State Street held its Rein Therapeutics (RNTX) position steady in Q1 2026 at 75,904 shares worth $98.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4029.

State Street first reported a position in RNTX in Q3 2017 and has held it in 17 quarters since. The position peaked at $342K in Q4 2017. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • State Street held 75,904 shares of Rein Therapeutics worth $98.7K as of Q1 2026.
  • State Street left its Rein Therapeutics share count unchanged in Q1 2026.
  • Rein Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4029 holding.
  • State Street first reported a position in Rein Therapeutics in Q3 2017 and has held it in 17 quarters since.
  • State Street's Rein Therapeutics position peaked at $342K in Q4 2017.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.